Baltimore Sun Examines FDA Initiative To Speed Approvals Of New Prescription Drugs (Medical News Today)
The Baltimore Sun on Friday examined an FDA initiative called Critical Path that aims to speed approvals of new prescription drugs. Advocates of quicker approvals say that by "streamlining the way scientists determine a new drug's safety and effectiveness, ... [click link for full article]

Cardium's Generx Advances To Phase 3 Following Meeting With FDA (Medical News Today)
Cardium Therapeutics, Inc (OTC Bulletin Board: CDTP) announced that Generx(TM) (alferminogene tadenovec) is to be advanced to a Phase 3 clinical trial in women as a potential treatment for myocardial ischemia (insufficient blood flow within the heart muscle), following an end-of-Phase 2 meeting with the U.S. Food and Drug Administration (FDA). [click link for full article]